Article

Issues in Clinical Trial Design - Lessons from the FDA's Rejection of MDMA

JAMA Psychiatry
DOI: 10.1001/jamapsychiatry.2025.0442
12Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Wilkinson, S. T., & Sanacora, G. (2025, June 4). Issues in Clinical Trial Design - Lessons from the FDA’s Rejection of MDMA. JAMA Psychiatry. American Medical Association. https://doi.org/10.1001/jamapsychiatry.2025.0442

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free